The last medicine was approved in 2002 and today we only have symptomatic treatments. ARUK-ODDI brings together chemists, biologist, psychiatrists and neuroscientists, many of them with pharmaceutical background, aiming to accelerate the discovery of novel and effective treatments, as explained by Dr John Davis.
John Davis: Why we work on Alzheimer’s disease
28 November 2016
The burden caused by Alzheimer’s disease and other dementias represents one of the biggest problems for our healthcare systems.